跳至主要内容
临床试验/NCT00848380
NCT00848380已完成不适用

Management of Cardiovascular Risk Factors

AstraZeneca1 个研究点 分布在 1 个国家目标入组 1,492 人开始时间: 2009年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
1,492
试验地点
1
主要终点
The goal is an evaluation of the development of the risk profile of cardiovascular patients with simultaneous treatment of hypertension and hyperlipidemia.

研究概览

简要总结

This practical experience should report a retrospective collection of data regarding cardiovascular risk factors of cardiovascular diseases. The goal is an evaluation of the development of the risk profile of cardiovascular patients with simultaneous treatment of hypertension and hyperlipidemia

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients received a anti-hypertension treatment in addition to cholesterol lowering treatment during the observation period
  • Patients received a cholesterol lowering treatment in addition to hypertension treatment during the observation period
  • Patients received during the observation time new cholesterol lowering and hypertension treatment

排除标准

  • Patients received during the observation time only cholesterol lowering or only anti-hypertension treatment

结局指标

主要结局

The goal is an evaluation of the development of the risk profile of cardiovascular patients with simultaneous treatment of hypertension and hyperlipidemia.

时间窗: Inclusion visit, 6 to 9 months before inclusion visit and / or 12 to 15 months before inclusion visit

次要结局

未报告次要终点

研究者

发起方
AstraZeneca
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验

Management of Cardiovascular Risk Factors | 临床试验